In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

Lauren (Hansen) Holznienkemper is a lead editor for the small business vertical at Forbes Advisor, specializing in HR, payroll and recruiting solutions for small businesses. Using research and writing ...

Regulatory pressure and consumer demand are accelerating the phaseout of petroleum-based dyes—and the replacement process is ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Wirecutter Staff You spent a pretty penny on a beautiful cashmere sweater, ...

Rajeev Dhir is a writer with 10+ years of experience as a journalist with a background in broadcast, print, and digital newsrooms. Suzanne is a content marketer, writer, and fact-checker. She holds a ...

Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction, after getting a green light from the EMA's human medicine committee.